Krebs Biochemicals & Industries Limited (BOM:524518)
India · Delayed Price · Currency is INR 64.43
-0.96 (-1.47%)
At close: May 29, 2026
BOM:524518 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | -169.33 | -269.39 | -197.28 | -246.92 | -445.27 |
Depreciation & Amortization | 64.23 | 65.05 | 65.82 | 63.75 | 56.58 |
Other Amortization | - | 1.84 | 1.84 | 1.84 | 6.39 |
Loss (Gain) From Sale of Assets | 0.16 | -1.22 | - | - | - |
Asset Writedown & Restructuring Costs | 18.64 | - | - | - | - |
Other Operating Activities | 55.87 | 58.42 | 51.18 | 32.59 | 51.14 |
Change in Accounts Receivable | 2.43 | 18.53 | -13.78 | 3.51 | -5.77 |
Change in Inventory | 3.28 | 37.65 | 21.49 | 136.17 | -89.62 |
Change in Accounts Payable | -29.17 | -8.18 | 36.89 | -226.26 | 171.3 |
Change in Other Net Operating Assets | 34.69 | 18.38 | 57.49 | -11.81 | 83.09 |
Operating Cash Flow | -19.21 | -78.91 | 23.65 | -247.13 | -172.16 |
Capital Expenditures | -31.72 | -35.63 | -94.15 | -151.58 | -270.78 |
Sale of Property, Plant & Equipment | 3.65 | 1.64 | 20.88 | - | - |
Other Investing Activities | -8.29 | -15.7 | -4.89 | 25.13 | 41.79 |
Investing Cash Flow | -36.36 | -49.7 | -78.17 | -126.45 | -229 |
Short-Term Debt Issued | 103.3 | 410.29 | - | - | - |
Long-Term Debt Issued | 23 | - | 102.54 | 403.17 | 323.84 |
Total Debt Issued | 126.3 | 410.29 | 102.54 | 403.17 | 323.84 |
Short-Term Debt Repaid | - | - | -0.61 | - | - |
Long-Term Debt Repaid | - | -222.5 | - | - | - |
Total Debt Repaid | - | -222.5 | -0.61 | - | - |
Net Debt Issued (Repaid) | 126.3 | 187.79 | 101.93 | 403.17 | 323.84 |
Issuance of Common Stock | - | - | - | - | 125.13 |
Other Financing Activities | -70.86 | -59.14 | -46.89 | -29.73 | -53.91 |
Financing Cash Flow | 55.44 | 128.65 | 55.03 | 373.43 | 395.06 |
Miscellaneous Cash Flow Adjustments | - | - | 0 | 0 | - |
Net Cash Flow | -0.13 | 0.04 | 0.52 | -0.15 | -6.1 |
Free Cash Flow | -50.92 | -114.54 | -70.5 | -398.71 | -442.95 |
Free Cash Flow Margin | -21.46% | -26.45% | -13.98% | -76.48% | -74.19% |
Free Cash Flow Per Share | -2.36 | -5.31 | -3.27 | -18.49 | -20.54 |
Cash Interest Paid | 70.86 | 59.08 | 46.86 | 29.71 | 53.85 |
Cash Income Tax Paid | - | 0.15 | - | - | - |
Levered Free Cash Flow | -74.97 | -57.76 | -37.27 | -336.06 | -332.22 |
Unlevered Free Cash Flow | -30.68 | -20.84 | -7.98 | -317.49 | -298.57 |
Change in Working Capital | 11.22 | 66.39 | 102.1 | -98.38 | 159 |